|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
Phase 1/2 study of fractionated dose lutetiumâ177âlabeled antiâprostateâspecific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer |
Vir: |
|
|
|
|
List of services to meet your request
Contains list of services for current record
Basic services |
|
|
Dodatne storitve |
|
|
© 2024 SFX by Ex Libris Inc. | Politika piškotkov
CrossRef Omogočeno
|